CORC

浏览/检索结果: 共6条,第1-6条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer 期刊论文
BMC CANCER, 2016, 卷号: 16
作者:  Sun, Yan;  Cheng, Ying;  Hao, Xuezhi;  Wang, Jie;  Hu, Chengping
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer 期刊论文
BMC Cancer, 2016, 卷号: 16, 期号: 1, 页码: 265
作者:  Sun, Yan*;  Cheng, Ying;  Hao, Xuezhi;  Wang, Jie;  Hu, Chengping
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/03
A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patients 期刊论文
2016, 卷号: 5, 期号: 6, 页码: 1116-1124
作者:  Mo, Hongnan;  Hao, Xuezhi;  Liu, Yutao;  Wang, Lin;  Hu, Xingsheng
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/04
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer 期刊论文
2016, 卷号: 16, 页码: 265
作者:  Sun, Yan;  Cheng, Ying;  Hao, Xuezhi;  Wang, Jie;  Hu, Chengping
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04
Clinical effect of pemetrexed as the first-line treatment in Chinese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer 期刊论文
2016, 卷号: 7, 期号: 4, 页码: 452-458
作者:  Ma, Di;  Hao, Xuezhi;  Wang, Yan;  Xing, Puyuan;  Li, Junling
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/04
Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases 期刊论文
2016, 卷号: 7, 期号: 51, 页码: 84666-84674
作者:  Xing, Puyuan
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace